BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

CARBOPLATIN Pages on BioPortfolio:

Biotechnology News CARBOPLATIN Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/CARBOPLATIN-news.htm...

BioPortfolio - Carboplatin
Updated Data from Initial Cohort Shows Nine of 14 Evaluable Patients Receiving Bavituximab in Combination with Carboplatin + Paclitaxel Achieved an ...
http://www.bioportfolio.com/indepth/Carboplatin.html...

Biotechnology News reolysin. oncolyt. reo. scchn. 74. calgari. Search
17 Nov 2009 ... The investigators reported that REOLYSIN was well tolerated when administered intravenously in combination with paclitaxel and carboplatin. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Lung Cancer: Eli Lilly's Affinitac to challenge the cytotoxics
Bristol-Myers Squibb (BMS) is a dominant force in the US lung cancer market by virtue of having Paraplatin (carboplatin), Platinol (cisplatin) and Taxol ...
http://www.bioportfolio.com/news/datamonitor_36.htm...

Biotechnology News reolysin. reo. scchn. oncolyt ...
17 Nov 2009 ... Oncolytics Biotech (ONCY) Announces Results of Phase I/II of REOLYSIN with Paclitaxel/Carboplatin for Advanced Cancers ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Gynaecological cancer treatment enters new era of patient-tailored ...
16 Oct 2009 ... Treating women with relapsed platinum-sensitive ovarian cancer with combined carboplatin and pegylated liposomal doxorubicin prolongs ...
http://www.bioportfolio.com/biotech_news/ESGO_1.htm...

Biotechnology News Telik Search
today announced the publication of the positive results from a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination with carboplatin and
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio News: - Oncolytics Biotech(R) Inc. Reaches...
All patients will receive treatment every three weeks (21 day cycles) with paclitaxel and carboplatin and will also receive, on a blinded basis, ...
http://www.bioportfolio.com/news/Oncolytics_Biotech(R)_Inc._...

Biotechnology News Drug Toxicity Search
Currently, paclitaxel and carboplatin given every three weeks is considered ... Currently, paclitaxel and carboplatin given every three weeks is considered ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - - Oncolytics Biotech(R) Inc. Reaches Special ...
examining REOLYSIN in combination with paclitaxel and carboplatin in patients with ... and carboplatin versus the chemotherapy alone in patients with ...
http://www.bioportfolio.com/news/Oncolytics_Biotech(R)_Inc._...

Results from other life science and pharmaceutical sites:

Carboplatin - Wikipedia, the free encyclopedia
5 Aug 2009 ... Carboplatin is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers). ...
http://en.wikipedia.org/wiki/Carboplatin...

Carboplatin: MedlinePlus Drug Information
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a695017.htm...

ACS :: Cancer Drug Guide: carboplatin
Carboplatin is a platinum chemotherapy drug that belongs to a group of drugs known as alkylating agents. It stops the growth of cancer cells, ...
http://www.cancer.org/docroot/CDG/content/CDG_carboplatin.as...

Definition of carboplatin - NCI Dictionary of Cancer Terms
Carboplatin is a form of the anticancer drug cisplatin and causes fewer side effects in patients. It attaches to DNA in cells and may kill cancer cells. ...
http://www.nci.nih.gov/dictionary/?CdrID=45182...

carboplatin (Carboplatin) injection, solution [Mayne Pharma (USA ...
Carboplatin Injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4173...

BioMed Central | Full text | DNA damage induced by cis- and ...
DNA damage after a one day treatment with cis- or carboplatin correlated well with the .... DNA damage induced by the crosslinkers cis- and carboplatin was
...
http://www.biomedcentral.com/1471-2407/9/359...

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
RESULTS: The 12-month rates of progression-free survival were 24.9% with gefitinib and 6.7% with carboplatin-paclitaxel. The study met its primary
objective ...
http://www.ncbi.nlm.nih.gov/pubmed/19692680...

Carboplatin--R&S PharmChem Co.,Ltd.
Carboplatin ( KAR-boe-pla-tin) belongs to the group of medicines known as alkylating agents. It is used to treat cancer of the ovaries. ...
http://www.rspharmchem.com/carboplatin.htm...

Radiotherapy versus single-dose carboplatin in adjuvant treatment ...
After good results in initial studies with one injection of carboplatin, we undertook a large randomised trial to compare the approaches of radiotherapy ...
http://www.ncbi.nlm.nih.gov/pubmed/16039331...

A randomised study of carboplatin vs sequential ifosfamide ...
In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.